Fragment-based QSAR and molecular modeling studies on a series of discodermolide analogs as microtubule-stabilizing anticancer agents

Abstract

Inhibition of microtubule function is an attractive rational approach to anticancer therapy. Although taxanes are the most prominent among the microtubule‐stabilizers, their clinical toxicity, poor pharmacokinetic properties, and resistance have stimulated the search for new antitumor agents having the same mechanism of action. Discodermolide is an example of nontaxane natural product that has the same mechanism of action, demonstrating superior antitumor efficacy and therapeutic index. The extraordinary chemical and biological properties have qualified discodermolide as a lead structure for the design of novel anticancer agents with optimized therapeutic properties. In the present work, we have employed a specialized fragment‐based method to develop robust quantitative structure–activity relationship models for a series of synthetic discodermolide analogs. The generated molecular recognition patterns were combined with three‐dimensional molecular modeling studies as a fundamental step on the path to understanding the molecular basis of drug–receptor interactions within this important series of potent antitumoral agents